Structural Heart Imaging Market Report by Imaging Modality (Echocardiogram, Angiogram), Procedure Type (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendag

Structural Heart Imaging Market Report by Imaging Modality (Echocardiogram, Angiogram), Procedure Type (Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Annuloplasty, Valvuloplasty, and Others), Application (Diagnosis, Surgery), End User (Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers, Catheterization Laboratories, and Others), and Region 2024-2032


The global structural heart imaging market size reached US$ 19.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 44.2 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032.

Structural heart imaging (SHI) is a special technique, which is extensively deployed in the healthcare industry for screening and examining the heart at the molecular level. This procedure includes the utilization of light reflection for producing the interior element images and creating a 2-dimensional cross-section analysis to get a clarified and accurate diagnosis. It is further used for enabling and assisting professionals while performing various operative procedures, such as locating the blockages and pathways for insertion by minimizing the risk of interference.

Structural Heart Imaging Market Trends:
The escalating prevalence of various congenital, cardiac diseases and lifestyle-induced ailments, such as obesity, diabetes, and high blood pressure due to excessive alcohol consumption and unhealthy eating habits, is one of the primary factors majorly driving the global heart imaging market toward the growth. Furthermore, the rising health consciousness amongst the consumers is positively influencing the market across the globe. In addition to this, the widespread adoption of SHI for addressing various heart conditions, such as non-valvular and valvular heart diseases, with the support of high precision and resolution cameras and sensors is considerably contributing to the market growth. Moreover, the introduction of transcatheter aortic valve replacement (TAVR) for operating heart diseases interventions by ensuring instant recovery of consumers post-surgery is promoting the growth of the market. Other than this, the rising investments in research and development (R&D) activities for introducing advanced structural heart imaging and cardiac systems is creating a positive outlook for the market. In line with this, the market is further being driven by the numerous initiatives undertaken by the governments of various nations for improving the healthcare infrastructure to ensure patients wellness.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global structural heart imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on imaging modality, procedure type, application and end user.

Breakup by Imaging Modality:

Echocardiogram
Angiogram
CT
MRI

Breakup by Procedure Type:

Transcatheter Aortic Valve Replacement (TAVR)
Surgical Aortic Valve Replacement (SAVR)
Transcatheter Mitral Valve Repair (TMVR)
Left Atrial Appendage Closure (LAAC)
Annuloplasty
Valvuloplasty
Others

Breakup by Application:

Diagnosis
Surgery

Breakup by End User:

Hospitals
Specialty Clinics
Cardiac Centers
Diagnostic Centers
Ambulatory Surgical Centers
Catheterization Laboratories
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Boston Scientific Corporation, Circle Cardiovascular Imaging Inc., Edwards Lifesciences Corporation, Integer Holdings Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., LivaNova PLC, Medtronic plc, Pie Medical Imaging B.V. and Siemens Healthcare GmbH.

Key Questions Answered in This Report

1. What was the size of the global structural heart imaging market in 2023?
2. What is the expected growth rate of the global structural heart imaging market during 2024-2032?
3. What are the key factors driving the global structural heart imaging market?
4. What has been the impact of COVID-19 on the global structural heart imaging market?
5. What is the breakup of the global structural heart imaging market based on the imaging modality?
6. What are the key regions in the global structural heart imaging market?
7. Who are the key players/companies in the global structural heart imaging market?


1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Structural Heart Imaging Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Imaging Modality
6.1 Echocardiogram
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Angiogram
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 CT
6.2.2.2 MRI
6.2.3 Market Forecast
7 Market Breakup by Procedure Type
7.1 Transcatheter Aortic Valve Replacement (TAVR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Surgical Aortic Valve Replacement (SAVR)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Transcatheter Mitral Valve Repair (TMVR)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Left Atrial Appendage Closure (LAAC)
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Annuloplasty
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Valvuloplasty
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by Application
8.1 Diagnosis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Surgery
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cardiac Centers
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Diagnostic Centers
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Ambulatory Surgical Centers
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Catheterization Laboratories
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Others
9.7.1 Market Trends
9.7.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Boston Scientific Corporation
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Circle Cardiovascular Imaging Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Edwards Lifesciences Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Integer Holdings Corporation
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Koninklijke Philips N.V.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Lepu Medical Technology (Beijing) Co. Ltd.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 LivaNova PLC
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.9 Medtronic plc
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Pie Medical Imaging B.V.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Siemens Healthcare GmbH
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings